Canal Biosciences, Inc.

LOWELL, MA · Founded 2024 · CIK 0002128163 · Biotech · Private

TrueLink NGS library preparation technology that eliminates the need for end repair in next-generation sequencing workflows

canalbiosciences.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$2.3M
1 Form D · Apr 2026
6 months since last filing
Contracts
—
No federal contracts on record
Patents
2
1 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$2,334,997
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1680MANDALMED, INC.——
1681PSQUARE SCIENTIFIC, LLC——
1682Madison Vaccines Inc—$2.4M
1683Canal Biosciences, Inc.—$2.3M
1684RENOVATE BIOSCIENCES, INC.——
1685CORE BIOTHERAPEUTICS INC——
1686HUMAN CELL CO——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Christopher BenoitDirector · Executive Officer
  • Jack PercoskieExecutive Officer
  • Yu ZhengDirector · Executive Officer

Patents

USPTO · 1 granted of 2

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.